Entero Healthcare Solutions Ltd IPO - Check Issue Date, Price, Lot Size & Details with BlinkX.

Entero Healthcare Solutions Ltd IPO

The Company's primary line of business is in the distribution of healthcare products to retail pharmacies, hospitals and healthcare clinics in India. The Company adds value to the healthcare product manufacturers that work with it by providing them reach and accessibility to pharmacies, hospitals and clinics through its integrated and technology driven, pan-India healthcare products distribution platform. As of September 30, 2023, its 77 warehouses located across the country, last-mile delivery infrastructure and relationships with pharmacies, hospitals and clinics enables healthcare product manufacturers to make their products available to a wide range of customers.

Entero Healthcare Solutions Ltd IPO Details

Total Shares Offered

₹ 1,27,18,601

Offer to Public

47,69,475

Retail Max (Shares)

₹ 12,65,501

Pre Issue Promoters Holding

₹ 2,74,06,428

Exchange

BSE

Issue size

₹ 1600 Cr

IPO Open Date

Feb 9, 2024

Close Date

Feb 13, 2024

Lot Size

Min Investment

₹ 13,145

Issue Type

Book Building

Listing Date

Feb 16, 2024

Entero Healthcare Solutions Ltd IPO Dates

Feb 9, 2024

Opening date

Feb 13, 2024

Closing date

Feb 14, 2024

Basis of Allotment

Feb 15, 2024

Initiation of Refunds

Feb 15, 2024

Credit of Shares

Feb 16, 2024

Listing date

Details

Sector	Type
Sector	Trading
Sub Sector	NA
Issue Type	Book Building

Subscription Status

*Values are in Lakhs

Investor Type	Subscription Times	Shares Offered*
QIB	0x	9491256
NII	0x	1898251
Retail	0x	1265501
Employee	0x	63593
Total	0x	12718601

Investor Type

QIB

NII

Retail

Employee

Total

Subscription Times

9491256

1898251

1265501

63593

12718601

Entero Healthcare Solutions Ltd Financial Status

Income Statement

Particulars (In Rs. Crores)

Balance Sheet

Particulars (In Rs. Crores)

Particulars (in Rs. Crores)	FY23	FY22	FY21
Revenue from operations	5,095.78	3,922.31	3,300.21
EBITDA	44.08	41.86	7.15
PAT	19.18	38.44	-12.46
Total Assets	790.40	1,675.16	673.00
Share Capital	43.51	43.49	667.73
Total Borrowings	411.50	721.82	492.50
Operating Activities (Net Cash)	27.83	47.19	-2.66
Investing Activities (Net Cash)	277.12	40.54	40.64
Financing Activities (Net Cash)	411.50	721.82	492.50
Net Cashflow	170.06	792.35	77.19

About Entero Healthcare Solutions Ltd

Entero Healthcare Solutions Limited was incorporated as Entero Healthcare Solutions Private Limited as a private limited company under the Companies Act, 2013 pursuant to a certificate of incorporation dated January 10, 2018, issued by the Registrar of Companies, Central Registration Centre, under the administrative control of the Registrar of Companies, Delhi and Haryana at New Delhi. Thereafter, the Company was converted into a public limited company pursuant to a special resolution passed in the annual general meeting of its Shareholders held on August 7, 2023, and consequently, the name of the Company was changed to `Entero Healthcare Solutions Limited', and a fresh certificate of incorporation dated August 25, 2023, was issued by the RoC.

The target addressable market for pharmaceutical distributors in India is valued at Rs. 2.7 trillion in the Financial Year 2023 and is expected to grow at 10% to 11% CAGR from the Financial Year 2023 to the Financial Year 2028. The distribution of pharmaceutical products in India is extremely fragmented with approximately 65,000 distributors, as of March 31, 2023, that generally service limited local areas only, unlike developed markets where large nationwide distributors occupy a dominant market position. In the Indian pharmaceutical distribution market, traditional local distributors have a 90-92% market share while large/national distributors have a 8-10% market share.

Peer Comparison:

Medplus Health Services Ltd

Entero Healthcare Solutions Ltd Key Points

Strengths

The Company operates in the large and highly fragmented Indian healthcare products distribution market and expect to benefit from market consolidation.

The Company is one of India's largest and fastest growing healthcare products distribution platforms.

The Company has a track record of inorganic expansion and integration to grow its geographic reach, revenues and scale.

The Company has a differentiated business model offering comprehensive and integrated commercial and supply chain solutions.

The Company has a proprietary technology platform with integrated business intelligence tools and solutions.

Risk

Since its inception, the company has completed a number of acquisitions of distributors in India to expand its business and increase its customer base, and may continue to complete more acquisitions in the future. However, its may be unable to realize the anticipated benefits of past or future acquisitions successfully. Further, if the company is unable to identify expansion opportunities or experience delays or other problems in implementing our strategy of inorganic growth, its business, financial condition, results of operations, cash flows and prospects may be adversely affected.

The company has experienced negative cash flows from operating, investing and financing activities in the past and may continue to do so in the future.

The company may incur losses and its reputation may be adversely affected by the return of the company products by customers, arising from the distribution of expired, unsafe, defective, ineffective or counterfeit products, and product spoilage, breakage and damage during transportation or in storage. Its may also be subject to product liability claims.

Strategy

Benefit from healthcare products distribution market consolidation with strategic acquisitions

Strengthen market position through increases in customer base, wallet share and geographic penetration

Pursue comprehensive marketing and distribution collaborations with healthcare product manufacturers

Expand its product adjacencies, private label and service offerings

Continue to invest in and leverage its technology, scale and synergistic adjacencies to drive efficiencies and profitability

How To Apply for Entero Healthcare Solutions Ltd IPO Online?

Step 1:

Step 2:

From the list of open IPOs, select the IPO you want to invest.

Step 3:

Go through the IPO details like lot size, price band, about the company, etc.

Step 4:

Click ‘Apply IPO’ to apply and enter the number of lots and bidding price along with your UPI ID.

Step 5:

Confirm your bid and accept the payment mandate sent to your UPI App for completing the IPO application.

FAQs on IPO (Initial Public Offering)

What is the issue size of the Entero Healthcare Solutions Ltd IPO?

Entero Healthcare Solutions Ltd's IPO offers shares for up to 1,000 It begins on Feb 9, 2024 and ends on Feb 13, 2024.

What is the price of the Entero Healthcare Solutions Ltd IPO?

The price of Entero Healthcare Solutions Ltd IPO ranges between ₹1,195 to ₹1258 per share.

What are the open and close dates for the Entero Healthcare Solutions Ltd IPO?

The Entero Healthcare Solutions Ltd IPO opens on Feb 9, 2024 and closes on Feb 13, 2024.

When will the Entero Healthcare Solutions Ltd IPO be allotted?

The allotment for the Entero Healthcare Solutions Ltd IPO will be finalised on Feb 14, 2024. The shares will be listed on BSE and NSE on Feb 16, 2024.

What is the minimum lot size required for Entero Healthcare Solutions Ltd IPO?

The minimum lot size for Entero Healthcare Solutions Ltd IPO is 11 shares, priced between ₹1195 to ₹1258 per share.

What is the GMP of Entero Healthcare Solutions Ltd IPO?

The GMP (Grey Market Premium) of Entero Healthcare Solutions Ltd IPO fluctuates based on market demand and sentiment.

How do you check the allotment status of Entero Healthcare Solutions Ltd IPO?

To check the allotment status of Entero Healthcare Solutions Ltd IPO, visit the registrar's website, select the IPO, enter your PAN Card number, Application Number, or DP Client ID, and click 'search.'

Where is the Entero Healthcare Solutions Ltd IPO getting listed?

The Entero Healthcare Solutions Ltd IPO is getting listed on the BSE and NSE. Bidding opens on Feb 9, 2024, and closes on Feb 13, 2024. The allotment is finalised on Feb 14, 2024.

How do you apply for the Entero Healthcare Solutions Ltd IPO?

To apply for the Entero Healthcare Solutions Ltd IPO, download the BlinkX app, complete KYC, select the IPO, enter bid details, and submit. Verify UPI payment for shares allotment.